| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.3 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |